Clinical Outcomes Prior to and Following Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial
2019
Background: The Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) provides early drug delivery and mechanical support similar to metallic drug-eluting stents, followed by complete res...
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
18
References
5
Citations
NaN
KQI